Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date20 Jul 2012 |
100 Clinical Results associated with ECODERM, Inc.
0 Patents (Medical) associated with ECODERM, Inc.
100 Deals associated with ECODERM, Inc.
100 Translational Medicine associated with ECODERM, Inc.